C World Wide Group Holding A Dynavax Technologies Corp Transaction History

C World Wide Group Holding A

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$2.94 - $9.1 $2.93 Million - $9.07 Million	-996,412 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$3.65 - $7.89 $1.83 Million - $3.95 Million	500,000 Added 100.72%	996,412 $3.98 Million
Q1 2019 May 03, 2019	BUY	$7.08 - $12.09 $42,826 - $73,132	6,049 Added 1.23%	496,412 $3.63 Million
Q4 2018 Feb 12, 2019	SELL	$8.14 - $13.28 $450,565 - $735,074	-55,352 Reduced 10.14%	490,363 $4.49 Million
Q3 2018 Nov 05, 2018	SELL	$11.85 - $16.0 $2.95 Million - $3.98 Million	-249,032 Reduced 31.33%	545,715 $6.77 Million
Q2 2018 Aug 03, 2018	BUY	$15.15 - $20.75 $798,889 - $1.09 Million	52,732 Added 7.11%	794,747 $12.1 Million
Q1 2018 May 03, 2018	SELL	$14.65 - $19.9 $416,440 - $565,677	-28,426 Reduced 3.69%	742,015 $14.7 Million
Q4 2017 Feb 07, 2018	SELL	$17.3 - $24.08 $923,543 - $1.29 Million	-53,384 Reduced 6.48%	770,441 $14.4 Million
Q3 2017 Nov 06, 2017	BUY	$15.2 - $21.5 $12.5 Million - $17.7 Million	823,825	823,825 $17.7 Million

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.